Westover Capital Advisors, LLC

Position in BSX — Boston Scientific Corp

CIK 1483467 WILMINGTON, DE

Position in BSX

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$341,799

-$170,707 QoQ

Shares Held

5,447

+1.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

21 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Westover Capital Advisors, LLC holds $1,921,941 across 3 Medical Devices names.

#	Ticker	Company	Shares	Value (USD)
1	AXGN	Axogen, Inc.	22,343	$1,032,023
2	ABT	Abbott Laboratories	7,500	$680,550
3	SYK	Stryker Corp	665	$209,368

21 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$341,799	5,447	+1.3%	Shares	Sole	2026-05-05
2025-12-31	$512,506	5,375	-66.1%	Shares	Sole	2026-02-09
2025-09-30	$1,548,509	15,861	+8.8%	Shares	Sole	2025-11-06
2025-06-30	$1,565,930	14,579	+6.1%	Shares	Sole	2025-08-11
2025-03-31	$1,385,889	13,738	-6.4%	Shares	Sole	2025-05-06
2024-12-31	$1,310,503	14,672	-2.6%	Shares	Sole	2025-02-06
2024-09-30	$1,262,949	15,071	-5.2%	Shares	Sole	2024-11-08
2024-06-30	$1,224,150	15,896	-6.8%	Shares	Sole	2024-08-08
2024-03-31	$1,167,891	17,052	+10.5%	Shares	Sole	2024-05-03
2023-12-31	$892,123	15,432	-1.5%	Shares	Sole	2024-02-06
2023-09-30	$827,006	15,663	-2.9%	Shares	Sole	2023-11-13
2023-06-30	$872,904	16,138	-6.5%	Shares	Sole	2023-08-11
2023-03-31	$863,417	17,258	-7.0%	Shares	Sole	2023-05-22
2022-12-31	$858,678	18,558	-0.5%	Shares	Sole	2023-05-18
2022-09-30	$722,624	18,658	+3.7%	Shares	Sole	2022-11-14
2022-06-30	$670,561	17,992	-0.1%	Shares	Sole	2022-08-12
2022-03-31	$797,308	18,002	+154.4%	Shares	Sole	2022-05-13
2021-12-31	$300,630	7,077	+24.0%	Shares	Sole	2022-02-14
2021-09-30	$247,626	5,707	+16.8%	Shares	Sole	2021-11-15
2021-06-30	$209,010	4,888	-45.6%	Shares	Sole	2021-08-10
2020-03-31	$293,278	8,988	—	Shares	Sole	2020-05-18
No filing history on record for this holder in this stock.